DENMARK - Vækstfonden invests $ 19.27m in series B round in Egalet
Vækstfonden has invested $19.27m in Egalet, a pharmaceutical company that specialises in oral controlled released products. The investment will be used to expand and optimise its proprietary product portfolio.
More on Expansion
The Bolt-Ons Digest – 26 January 2023
Unquote’s selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons
The Bolt-Ons Digest – 14 December 2022
Unquote’s selection of the latest add-ons, including CVC's Stark Group, Bridgepoint's Kereis, EQT's Open Systems, and more
Highland Europe leads EUR 60m round for Le Collectionist
France-based luxury holiday company is aiming for market consolidation following the fresh funding
Latest News
Bowmark bolsters investment team with two hires
Laura Clayfield and Raj Mukherji have joined the London-based mid-market sponsor
Capiton moves two assets to continuation vehicle; Fund V largely unrealised
Eurazeo and Unigestion among LPs in new fund for industrial tech businesses Raith and AEMtec
BlackRock mulls new vintage of private capital products for sophisticated retail investors in Europe
Global asset manager explores new generation of private market funds for wealthy individuals banking on positive uptake from retail investors
LDC outlines plans for new record year of deployment
Despite macro woes, sponsor wants to build up on last year’s pace of investment and exceed GBP 400m mark in 2023